# Levothyroxine in Pregnant SLE Patients

> **NCT01276782** · PHASE4 · WITHDRAWN · sponsor: **Johns Hopkins University**

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **DRUG:** Levothyroxine

## Key facts

- **NCT ID:** NCT01276782
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-01
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Withdraw the study because further analysis showed that it would be futile.
- **Last updated:** 2015-09-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01276782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01276782, "Levothyroxine in Pregnant SLE Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01276782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*